ReflexMD states it is not a covered entity under HIPAA directly and may act as a business associate to its pharmacy and medical group partners. US-only service.
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
Cancellation and Refund
Cancellation line (distinct from support 888-807-2462): phone-required: +1 (866) 849-6382, 2 days before renewal. California residents may also email help@reflexmd.com.